Yoshimasa Nobeyama

55PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NanomedicineMolecular targetsPacific Peoples social determinants of healthJapanese language
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Sep 06, 2026
Outcomes of Curative-Intent Endoscopic Resection Combined With Adjuvant Immune Checkpoint Inhibition for Resectable Sinonasal Mucosal Melanoma.

|Jul 14, 2026
Topical β-Blocker as a Novel Treatment Option for Periungual Pyogenic Granuloma: A Retrospective Study of Lesion Size Reduction and Pain Improvement.

|Apr 08, 2026
Clinical Features of Nasal and Paranasal Mucosal Melanomas in the Era of Immune Checkpoint Inhibitors: Insights From a Single-Institution Analysis.

Yuma Waki, Teru Ebihara, Kazuhiro Omura

|Apr 02, 2026
One-year outcome trends in Japanese patients with rosacea: insights from a real-world study.

Yoshimasa Nobeyama, Yoshiko Aihara

|Mar 13, 2026
An Attempt to Establish the Consensus Regarding the Diagnosis, Classification, and Treatment of Rosacea in Japan Using a Modified Delphi Method: The Japan Rosacea Consensus.

Kenshi Yamasaki, Nobukazu Hayashi, Hiroaki Hayashi

|Oct 14, 2025
Nail manifestations reflecting abnormalities of bone and soft tissues in interphalangeal joints affected by psoriatic arthritis.

Mayumi Ota, Akihiko Asahina, Yoshimasa Nobeyama

Pageof 10

Frequent Collaborators

16 joint publications

Akihiko Asahina

7 joint publications

Yuma Waki

4 joint publications

Itaru Dekio

3 joint publications

Yoshinori Watanabe